| Impaired inhibitory control of behavior in chronic cocaine users MT Fillmore, CR Rush Drug and alcohol dependence 66 (3), 265-273, 2002 | 621 | 2002 |
| Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review SH Kollins, EK MacDonald, CR Rush Pharmacology Biochemistry and Behavior 68 (3), 611-627, 2001 | 458 | 2001 |
| Acute effects of cocaine in two models of inhibitory control: implications of non‐linear dose effects MT Fillmore, CR Rush, L Hays Addiction 101 (9), 1323-1332, 2006 | 175 | 2006 |
| Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status TH Kelly, G Robbins, CA Martin, MT Fillmore, SD Lane, NG Harrington, ... Psychopharmacology 189, 17-25, 2006 | 173 | 2006 |
| Acute effects of oral cocaine on inhibitory control of behavior in humans MT Fillmore, CR Rush, L Hays Drug and alcohol dependence 67 (2), 157-167, 2002 | 166 | 2002 |
| Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. SH Kollins, CR Rush, PJ Pazzaglia, JA Ali Experimental and clinical psychopharmacology 6 (4), 367, 1998 | 146 | 1998 |
| Validation of the multiple-choice procedure for investigating drug reinforcement in humans. RR Griffiths, CR Rush, KA Puhala Experimental and Clinical Psychopharmacology 4 (1), 97, 1996 | 138 | 1996 |
| Behavioral pharmacology of zolpidem relative to benzodiazepines: a review CR Rush Pharmacology biochemistry and behavior 61 (3), 253-269, 1998 | 137 | 1998 |
| Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non–drug-abusing humans CR Rush, WD Essman, CA Simpson, RW Baker Journal of clinical psychopharmacology 21 (3), 273-286, 2001 | 136 | 2001 |
| Evaluation of the “pipeline” for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research PW Czoty, WW Stoops, CR Rush Pharmacological reviews 68 (3), 533-562, 2016 | 131 | 2016 |
| Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. CR Rush, SH Kollins, PJ Pazzaglia Experimental and clinical psychopharmacology 6 (1), 32, 1998 | 127 | 1998 |
| Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers CR Rush, RR Griffiths Journal of clinical psychopharmacology 16 (2), 146-157, 1996 | 125 | 1996 |
| Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control MT Fillmore, CR Rush Journal of psychopharmacology 20 (1), 24-32, 2006 | 124 | 2006 |
| Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans CR Rush, RW Baker, K Wright Psychopharmacology 144, 220-233, 1999 | 124 | 1999 |
| Acute behavioral and physiological effects of modafinil in drug abusers CR Rush, TH Kelly, LR Hays, RW Baker, AF Wooten Behavioural pharmacology 13 (2), 105-115, 2002 | 123 | 2002 |
| Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies DV Herin, CR Rush, J Grabowski Annals of the New York Academy of Sciences 1187 (1), 76-100, 2010 | 120 | 2010 |
| Zaleplon and triazolam in humans: acute behavioral effects and abuse potential CR Rush, JM Frey, RR Griffiths Psychopharmacology 145, 39-51, 1999 | 110 | 1999 |
| Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. CR Rush, RW Baker Experimental and clinical psychopharmacology 9 (1), 59, 2001 | 102 | 2001 |
| Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans ST Higgins, CR Rush, WK Bickel, JR Hughes, M Lynn, MA Capeless Psychopharmacology 111, 285-294, 1993 | 102 | 1993 |
| Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans CR Rush, WW Stoops, LR Hays, PEA Glaser, LS Hays Journal of Pharmacology and Experimental Therapeutics 306 (1), 195-204, 2003 | 100 | 2003 |
